Claritev Corporation Class A CTEV
NYSE · United States · Technology Services
$21.17-0.47 (-2.17%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
MCLEAN, Va., September 22, 2026--Claritev Corporation (NYSE: CTEV), a healthcare technology, data, and insights company focused on making healthcare more affordable, transparent and fair for all, has been selected by General Dynamics Information Technology (GDIT) to support the World Trade Center (WTC) Health Program. The WTC Health Program is a limited federal health care program established under the James Zadroga 9/11 Health and Compensation Act of 2010 (Extended in 2015). It provides nationw
MCLEAN, Va., September 17, 2026--Claritev Corporation ("Claritev" or the "Company") (NYSE: CTEV), a healthcare technology, data, and insights company, today announced the publication of its 2025 Corporate Responsibility Report.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
MCLEAN, Va., September 15, 2026--Claritev Corporation ("Claritev" or the "Company") (NYSE: CTEV), a technology, data, and insights company, today announced that its Board of Directors ("Board") has appointed Ben Letham as a director, effective September 14, 2026, to fill a vacancy on the Board. Letham’s extensive experience in artificial intelligence (AI) will enhance the Board’s depth of expertise and support the Company’s long-term strategic objectives.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.